<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.drugwiki.net/wen/index.php?action=history&amp;feed=atom&amp;title=Talk%3AAgmatine</id>
	<title>Talk:Agmatine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.drugwiki.net/wen/index.php?action=history&amp;feed=atom&amp;title=Talk%3AAgmatine"/>
	<link rel="alternate" type="text/html" href="https://www.drugwiki.net/wen/index.php?title=Talk:Agmatine&amp;action=history"/>
	<updated>2026-11-06T19:39:09Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://www.drugwiki.net/wen/index.php?title=Talk:Agmatine&amp;diff=9043&amp;oldid=prev</id>
		<title>Sysop: 1 revision imported</title>
		<link rel="alternate" type="text/html" href="https://www.drugwiki.net/wen/index.php?title=Talk:Agmatine&amp;diff=9043&amp;oldid=prev"/>
		<updated>2025-11-01T14:17:57Z</updated>

		<summary type="html">&lt;p&gt;1 revision imported&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:17, 1 November 2025&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-notice&quot; lang=&quot;en&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(No difference)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</summary>
		<author><name>Sysop</name></author>
	</entry>
	<entry>
		<id>https://www.drugwiki.net/wen/index.php?title=Talk:Agmatine&amp;diff=9042&amp;oldid=prev</id>
		<title>en&gt;Brack: created agmatine page; added pharmacology and effects</title>
		<link rel="alternate" type="text/html" href="https://www.drugwiki.net/wen/index.php?title=Talk:Agmatine&amp;diff=9042&amp;oldid=prev"/>
		<updated>2022-07-18T02:34:28Z</updated>

		<summary type="html">&lt;p&gt;created agmatine page; added pharmacology and effects&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&lt;br /&gt;
{{decree|type=notice|message=This article is in the &amp;#039;Talk&amp;#039; namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you&amp;#039;d like to use this area to discuss this draft, please do so in the &amp;#039;Discussion&amp;#039; section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}}&lt;br /&gt;
&lt;br /&gt;
{{headerpanel|{{Approval}}}}&lt;br /&gt;
{{SummarySheet}}&lt;br /&gt;
{{SubstanceBox/Example}}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- Please ensure that any new substance articles are first published in the &amp;#039;Talk&amp;#039; namespace. For example, a new article on substance XYZ should have the title &amp;quot;Talk: XYZ&amp;quot; instead of &amp;quot;XYZ&amp;quot;. Once the submitted article has been reviewed and determined to meet the guidelines and standards, it will be published by a staff member. --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
For tips on how to properly format a substance article, please refer to this document: [[Content Style Guide - Substance]]&lt;br /&gt;
&lt;br /&gt;
==History and culture==&lt;br /&gt;
{{historyStub}}&lt;br /&gt;
&lt;br /&gt;
==Chemistry==&lt;br /&gt;
{{chemistry}}&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
{{pharmacology}}&lt;br /&gt;
Agmatine acts as an [[NMDA]] receptor antagonist, a2 adrenergic receptor antagonist, and imidazoline receptor agonist.&amp;lt;ref&amp;gt;[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748779/ Crespi (2019) Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment]&amp;lt;/ref&amp;gt;&lt;br /&gt;
==Subjective effects==&lt;br /&gt;
{{EffectStub}}&lt;br /&gt;
{{Preamble/SubjectiveEffects}}&lt;br /&gt;
{{effects/base&lt;br /&gt;
&lt;br /&gt;
|{{effects/physical|&lt;br /&gt;
If applicable, a brief paragraph summary of the substance&amp;#039;s physical effects may be included here. &lt;br /&gt;
&lt;br /&gt;
You may select physical effects to add below [[Subjective effect index#Physical effects|here]].&lt;br /&gt;
&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Pain relief]]&amp;#039;&amp;#039;&amp;#039;&amp;lt;ref&amp;gt;[https://www.researchgate.net/profile/Tayfun-Uzbay/publication/51619445_The_pharmacological_importance_of_agmatine_in_the_brain/links/5a3c04590f7e9b10e23bb734/The-pharmacological-importance-of-agmatine-in-the-brain.pdf?_sg%5B0%5D=started_experiment_milestone&amp;amp;origin=journalDetail Uzbay (2011) The Pharmacological Importance of Agmatine in the Brain]&amp;lt;/ref&amp;gt; &lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Stimulation]] or [[Effect::Sedation]]&amp;#039;&amp;#039;&amp;#039; - Some individuals experience mild stimulation from agmatine, while others report mild sedation&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Nausea]]&amp;#039;&amp;#039;&amp;#039; - This effect is more prominent at high doses&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Stomach bloating]]&amp;#039;&amp;#039;&amp;#039; - This effect is more prominent at high doses&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Vasodilation]]&amp;#039;&amp;#039;&amp;#039; - Agmatine is shown to be a potent vasodilator, and is commonly supplemented by body builders for this purpose&amp;lt;ref&amp;gt;[https://www.sciencedirect.com/science/article/pii/0024320595020117 Gao et al. (1995) Agmatine: A Novel Endogenous Vasodilator Substance]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Physical euphoria]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Muscle relaxation]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Hypogylcemia]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
}}&lt;br /&gt;
{{effects/visual|&lt;br /&gt;
If applicable, a brief paragraph summary of the substance&amp;#039;s visual effects may be included here. &lt;br /&gt;
&lt;br /&gt;
You may select visual effects to add below [[Subjective effect index#Visual effects|here]].&lt;br /&gt;
&lt;br /&gt;
====Enhancements====&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Visual acuity effect1]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
====Distortions====&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Visual distortion effect1]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
====[[Effect::Geometry]]====&lt;br /&gt;
If applicable, a brief paragraph summary describing the visual geometry produced by the substance may be included here.&lt;br /&gt;
====Hallucinatory states====&lt;br /&gt;
If applicable, a brief summary of the substance&amp;#039;s visual effects profile may be written here.&lt;br /&gt;
&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Hallucinatory states1]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
|{{effects/cognitive|&lt;br /&gt;
If applicable, a brief paragraph summary of the substance&amp;#039;s cognitive effects may be included here. &lt;br /&gt;
&lt;br /&gt;
You may select from a list of cognitive effects to add below [[Subjective effect index#Cognitive effects|here]].&lt;br /&gt;
&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Psychosis]]&amp;#039;&amp;#039;&amp;#039; - Increased blood agmatine is associated with psychosis, and the administration of agmatine increases cognitive markers of psychosis &amp;lt;ref&amp;gt;[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748779/ Crespi (2019) Comparative psychopharmacology of autism and psychotic-affective disorders suggests new targets for treatment]&amp;lt;/ref&amp;gt;, however it is unlikely in regular doses to produce psychotic symptoms in healthy individuals&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Anxiety suppression]]&amp;#039;&amp;#039;&amp;#039;&amp;lt;ref&amp;gt;[https://www.researchgate.net/profile/Tayfun-Uzbay/publication/51619445_The_pharmacological_importance_of_agmatine_in_the_brain/links/5a3c04590f7e9b10e23bb734/The-pharmacological-importance-of-agmatine-in-the-brain.pdf?_sg%5B0%5D=started_experiment_milestone&amp;amp;origin=journalDetail Uzbay (2011) The Pharmacological Importance of Agmatine in the Brain]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Motivation enhancement]]&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Addiction suppression]]&amp;#039;&amp;#039;&amp;#039; - Agmatine has shown to have remarkable efficacy in reducing the withdrawal symptoms of several different classes of addictive substances, as well as reducing addictive behaviors&amp;lt;ref&amp;gt;[https://www.researchgate.net/profile/Tayfun-Uzbay/publication/51619445_The_pharmacological_importance_of_agmatine_in_the_brain/links/5a3c04590f7e9b10e23bb734/The-pharmacological-importance-of-agmatine-in-the-brain.pdf?_sg%5B0%5D=started_experiment_milestone&amp;amp;origin=journalDetail Uzbay (2011) The Pharmacological Importance of Agmatine in the Brain]&amp;lt;/ref&amp;gt; &lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Empathy, affection, and sociability enhancement]]&amp;#039;&amp;#039;&amp;#039; - This effect is milder when compared to substances such as [[MDMA]]&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Emotion enhancement]]&amp;#039;&amp;#039;&amp;#039; - Agmatine is anecdotally reported to enhance positive emotions and reduce anhedonia, however some users report mild anhedonia from taking agmatine&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Dream potentiation]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Cognitive euphoria]]&amp;#039;&amp;#039;&amp;#039; - This effect is milder in comparison to other dissociatives such as [[DXM]]&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Increased music appreciation]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Increased libido]]&amp;#039;&amp;#039;&amp;#039; or &amp;#039;&amp;#039;&amp;#039;[[Decreased libido]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Insomnia]]&amp;#039;&amp;#039;&amp;#039; - Agmatine produces insomnia in some individuals when taken late in the day&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
}}&lt;br /&gt;
{{effects/auditory|&lt;br /&gt;
If applicable, a brief paragraph summary of the substance&amp;#039;s auditory effects may be included here. &lt;br /&gt;
&lt;br /&gt;
You may select from a list of auditory effects to add below [[Subjective effect index#Auditory effects|here]].&lt;br /&gt;
&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Auditory effect1]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Auditory effect2]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
}}&lt;br /&gt;
{{effects/multisensory|&lt;br /&gt;
If applicable, a brief paragraph summary of the substance&amp;#039;s multisensory effects may be included here. &lt;br /&gt;
&lt;br /&gt;
You may select from a list of multisensory effects to add below [[Subjective effect index#Multisensory effects|here]].&lt;br /&gt;
&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Multisensory effect1]]&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Multisensory effect2]]&amp;#039;&amp;#039;&amp;#039; &lt;br /&gt;
&lt;br /&gt;
}}&lt;br /&gt;
{{effects/transpersonal|&lt;br /&gt;
If applicable, a brief paragraph summary of the substance&amp;#039;s transpersonal effects may be included here. &lt;br /&gt;
&lt;br /&gt;
You may select from a list of transpersonal effects to add below [[Subjective effect index#Transpersonal effects|here]].&lt;br /&gt;
&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Transpersonal effect1]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
*&amp;#039;&amp;#039;&amp;#039;[[Effect::Transpersonal effect2]]&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
}}&lt;br /&gt;
}}&lt;br /&gt;
===Experience reports===&lt;br /&gt;
There are currently {{#ask:[[Category:SUBSTANCE]][[Category:Experience]] | format=count}} experience reports which describe the effects of this substance in our [[experience index]].&lt;br /&gt;
{{#ask: [[Category:SUBSTANCE]][[Category:Experience]]|format=ul|Columns=1}}&lt;br /&gt;
Additional experience reports can be found here:&lt;br /&gt;
* [https://www.erowid.org/experiences/subs/exp_SUBSTANCE.shtml Erowid Experience Vaults: SUBSTANCE] &amp;lt;!-- Check the link to see if it exists --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Toxicity and harm potential==&lt;br /&gt;
{{toxicity}}&lt;br /&gt;
It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this substance.&lt;br /&gt;
===Lethal dosage===&lt;br /&gt;
===Tolerance and addiction potential===&lt;br /&gt;
===Dangerous interactions===&lt;br /&gt;
{{DangerousInteractions}}&lt;br /&gt;
{{DangerousInteractions/Intro}}&lt;br /&gt;
&lt;br /&gt;
==Legal status==&lt;br /&gt;
{{LegalStub}}&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Responsible use]]&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
(List along order below)&lt;br /&gt;
* [https://en.wikipedia.org/wiki/SUBSTANCE SUBSTANCE (Wikipedia)]&lt;br /&gt;
* SUBSTANCE (Erowid Vault)&lt;br /&gt;
* SUBSTANCE ([&amp;#039;&amp;#039;PiHKAL&amp;#039;&amp;#039; or &amp;#039;&amp;#039;TiHKAL&amp;#039;&amp;#039;] / Isomer Design)&lt;br /&gt;
&lt;br /&gt;
==Literature==&lt;br /&gt;
* APA formatted reference &lt;br /&gt;
&lt;br /&gt;
Please see the [[citation formatting guide]] if you need assistance properly formatting citations.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Psychoactive substance]][[Category:Proofread]][[Category:Approval]][[Category:Nootropic]][[Category:Dissociative]]&lt;/div&gt;</summary>
		<author><name>en&gt;Brack</name></author>
	</entry>
</feed>